Back to Search
Start Over
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review
- Source :
- PR Newswire. February 16, 2017
- Publication Year :
- 2017
-
Abstract
- Second Successful BLA Filing of the Partnership in the U.S. HERTFORDSHIRE, England, PITTSBURGH and®BENGALURU, India, Feb. 16, 2017 /PRNewswire/ --®Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.482244019